ML1419c peptide immunization induces Mycobacterium leprae-specific HLA-A*0201-restricted CTL in vivo with potential to kill live mycobacteria

Journal of Immunology

Volumn 187, Issue 3, 2011, Pages 1393-1402

  Geluk, Annemieke ^a   Van Den Eeden, Susan J F ^a   Dijkman, Karin ^a   Wilson, Louis ^a   Kim, Hee Jin ^b   Franken, Kees L M C ^a   Spencer, John S ^b   Pessolani, Maria C V ^c   Pereira, Geraldo M B ^c,d   Ottenhoff, Tom H M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Department of Environmental and Radiological Health Sciences   (United States)

^c INSTITUTO OSWALDO CRUZ   (Brazil)

^d STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CXCL9 CHEMOKINE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; HLA A ANTIGEN; IMMUNOGLOBULIN G; PEPTIDE VACCINE; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B LYMPHOCYTE; BACTERICIDAL ACTIVITY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL MEDIATED CYTOTOXICITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; CYTOTOXIC T LYMPHOCYTE; DRUG POTENCY; IMMUNIZATION; IN VIVO STUDY; LEPROSY; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; MOUSE; MYCOBACTERIUM LEPRAE; MYCOBACTERIUM SMEGMATIS; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; WILD TYPE;

AMINO ACID SEQUENCE; ANIMALS; B-LYMPHOCYTE SUBSETS; BACTERIAL PROTEINS; BACTERIAL VACCINES; CELLS, CULTURED; CYTOTOXICITY TESTS, IMMUNOLOGIC; EPITOPES, T-LYMPHOCYTE; HLA-A ANTIGENS; HUMANS; LEPROSY; MICE; MICE, TRANSGENIC; MOLECULAR SEQUENCE DATA; MYCOBACTERIUM LEPRAE; PEPTIDE FRAGMENTS; T-LYMPHOCYTES, CYTOTOXIC; T-LYMPHOCYTES, HELPER-INDUCER; VACCINES, SUBUNIT;

EID: 80051625548     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1100980     Document Type: Article

References (46)

1. Mogues, T., M. E. Goodrich, L. Ryan, R. LaCourse, and R. J. North. 2001. The relative importance of T cell subsets in immunity and immunopathology of airborne Mycobacterium tuberculosis infection in mice. J. Exp. Med. 193: 271-280. (Pubitemid 32524511)
2. Kaufmann, S. H. 1988. CD8+ T lymphocytes in intracellular microbial infections. Immunol. Today 9: 168-174.
3. van Pinxteren, L. A., J. P. Cassidy, B. H. Smedegaard, E. M. Agger, and P. Andersen. 2000. Control of latent Mycobacterium tuberculosis infection is dependent on CD8 T cells. Eur. J. Immunol. 30: 3689-3698. (Pubitemid 32005243)
4. Bruns, H., C. Meinken, P. Schauenberg, G. Härter, P. Kern, R. L. Modlin, C. Antoni, and S. Stenger. 2009. Anti-TNF immunotherapy reduces CD8+ T cell-mediated antimicrobial activity against Mycobacterium tuberculosis in humans. J. Clin. Invest. 119: 1167-1177.
5. Ottenhoff, T. H., and T. Mutis. 1995. Role of cytotoxic cells in the protective immunity against and immunopathology of intracellular infections. Eur. J. Clin. Invest. 25: 371-377.
6. Britton, W. J., and D. N. Lockwood. 2004. Leprosy. Lancet 363: 1209-1219. (Pubitemid 38481849)
7. Ridley, D. S., and W. H. Jopling. 1966. Classification of leprosy according to immunity. A five-group system. Int. J. Lepr. Other Mycobact. Dis. 34: 255-273.
8. Adams, L. B., D. M. Scollard, N. A. Ray, A. M. Cooper, A. A. Frank, I. M. Orme, and J. L. Krahenbuhl. 2002. The study of Mycobacterium leprae infection in interferon-gamma gene-disrupted mice as a model to explore the immunopathologic spectrum of leprosy. J. Infect. Dis. 185(Suppl 1): S1-S8. (Pubitemid 34142823)
9. Ottenhoff, T. H., and R. R. de Vries. 1987. HLA class II immune response and suppression genes in leprosy. Int. J. Lepr. Other Mycobact. Dis. 55: 521-534.
10. Ottenhoff, T. H., J. B. Haanen, A. Geluk, T. Mutis, B. K. Ab, J. E. Thole, W. C. van Schooten, P. J. van den Elsen, and R. R. de Vries. 1991. Regulation of mycobacterial heat-shock protein-reactive T cells by HLA class II molecules: lessons from leprosy. Immunol. Rev. 121: 171-191.
11. Misch, E. A., W. R. Berrington, J. C. Vary, Jr., and T. R. Hawn. 2010. Leprosy and the human genome. Microbiol. Mol. Biol. Rev. 74: 589-620.
12. Zhang, F. R., W. Huang, S. M. Chen, L. D. Sun, H. Liu, Y. Li, Y. Cui, X. X. Yan, H. T. Yang, R. D. Yang, et al. 2009. Genomewide association study of leprosy. N. Engl. J. Med. 361: 2609-2618.
13. Global leprosy situation, 2010. Wkly. Epidemiol. Rec. 85: 337-348.
14. Lockwood, D. N., and S. Suneetha. 2005. Leprosy: too complex a disease for a simple elimination paradigm. Bull. World Health Organ. 83: 230-235. (Pubitemid 40387165)
15. Scollard, D. M., L. B. Adams, T. P. Gillis, J. L. Krahenbuhl, R. W. Truman, and D. L. Williams. 2006. The continuing challenges of leprosy. Clin. Microbiol. Rev. 19: 338-381.
16. Moet, F. J., A. Meima, L. Oskam, and J. H. Richardus. 2004. Risk factors for the development of clinical leprosy among contacts, and their relevance for targeted interventions. Lepr. Rev. 75: 310-326.
17. Monot, M., N. Honoré, T. Garnier, N. Zidane, D. Sherafi, A. Paniz-Mondolfi, M. Matsuoka, G. M. Taylor, H. D. Donoghue, A. Bouwman, et al. 2009. Comparative genomic and phylogeographic analysis of Mycobacterium leprae. Nat. Genet. 41: 1282-1289.
18. Geluk, A., M. R. Klein, K. L. Franken, K. E. van Meijgaarden, B. Wieles, K. C. Pereira, S. Bührer-Sékula, P. R. Klatser, P. J. Brennan, J. S. Spencer, et al. 2005. Postgenomic approach to identify novel Mycobacterium leprae antigens with potential to improve immunodiagnosis of infection. Infect. Immun. 73: 5636-5644. (Pubitemid 41192999)
19. Geluk, A., J. S. Spencer, K. Bobosha, M. C. Pessolani, G. M. Pereira, S. Banu, N. Honoré, S. T. Reece, M. MacDonald, B. R. Sapkota, et al IDEAL Consortium. 2009. From genome-based in silico predictions to ex vivo verification of leprosy diagnosis. Clin. Vaccine Immunol. 16: 352-359.
20. Geluk, A., J. van der Ploeg, R. O. Teles, K. L. Franken, C. Prins, J. W. Drijfhout, E. N. Sarno, E. P. Sampaio, and T. H. Ottenhoff. 2008. Rational combination of peptides derived from different Mycobacterium leprae proteins improves sensitivity for immunodiagnosis of M. leprae infection. Clin. Vaccine Immunol. 15: 522-533. (Pubitemid 351967078)
21. Spencer, J. S., H. M. Dockrell, H. J. Kim, M. A. Marques, D. L. Williams, M. V. Martins, M. L. Martins, M. C. Lima, E. N. Sarno, G. M. Pereira, et al. 2005. Identification of specific proteins and peptides in mycobacterium leprae suitable for the selective diagnosis of leprosy. J. Immunol. 175: 7930-7938. (Pubitemid 41798353)
22. Kaleab, B., T. Ottenoff, P. Converse, E. Halapi, G. Tadesse, M. Rottenberg, and R. Kiessling. 1990. Mycobacterial-induced cytotoxic T cells as well as non-specific killer cells derived from healthy individuals and leprosy patients. Eur. J. Immunol. 20: 2651-2659.
23. Modlin, R. L., J. Melancon-Kaplan, S. M. Young, C. Pirmez, H. Kino, J. Convit, T. H. Rea, and B. R. Bloom. 1988. Learning from lesions: patterns of tissue inflammation in leprosy. Proc. Natl. Acad. Sci. USA 85: 1213-1217. (Pubitemid 18073979)
24. Ruppert, J., J. Sidney, E. Celis, R. T. Kubo, H. M. Grey, and A. Sette. 1993. Prominent role of secondary anchor residues in peptide binding to HLA-A2.1 molecules. Cell 74: 929-937. (Pubitemid 23270612)
25. Geluk, A., K. E. van Meijgaarden, K. L. Franken, J. W. Drijfhout, S. D'Souza, A. Necker, K. Huygen, and T. H. Ottenhoff. 2000. Identification of major epitopes of Mycobacterium tuberculosis AG85B that are recognized by HLAA*0201-restricted CD8+ T cells in HLA-transgenic mice and humans. J. Immunol. 165: 6463-6471.
26. Gram, G. J., I. Karlsson, E. M. Agger, P. Andersen, and A. Fomsgaard. 2009. A novel liposome-based adjuvant CAF01 for induction of CD8(+) cytotoxic T-lymphocytes (CTL) to HIV-1 minimal CTL peptides in HLA-A*0201 transgenic mice. PLoS ONE 4: e6950.
27. Newberg, M. H., D. H. Smith, S. B. Haertel, D. R. Vining, E. Lacy, and V. H. Engelhard. 1996. Importance of MHC class 1 alpha2 and alpha3 domains in the recognition of self and non-self MHC molecules. J. Immunol. 156: 2473-2480. (Pubitemid 26091573)
28. Juffermans, N. P., J. C. Leemans, S. Florquin, A. Verbon, A. H. Kolk, P. Speelman, S. J. van Deventer, and T. van der Poll. 2002. CpG oligodeoxynucleotides enhance host defense during murine tuberculosis. Infect. Immun. 70: 147-152. (Pubitemid 34028611)
29. Joosten, S. A., K. E. van Meijgaarden, N. D. Savage, T. de Boer, F. Triebel, A. van der Wal, E. de Heer, M. R. Klein, A. Geluk, and T. H. Ottenhoff. 2007. Identification of a human CD8+ regulatory T cell subset that mediates suppression through the chemokine CC chemokine ligand 4. Proc. Natl. Acad. Sci. USA 104: 8029-8034. (Pubitemid 47185870)
30. Duthie, M. S., W. Goto, G. C. Ireton, S. T. Reece, L. P. Cardoso, C. M. Martelli, M. M. Stefani, M. Nakatani, R. C. de Jesus, E. M. Netto, et al. 2007. Use of protein antigens for early serological diagnosis of leprosy. Clin. Vaccine Immunol. 14: 1400-1408. (Pubitemid 350304031)
31. Groathouse, N. A., A. Amin, M. A. Marques, J. S. Spencer, R. Gelber, D. L. Knudson, J. T. Belisle, P. J. Brennan, and R. A. Slayden. 2006. Use of protein microarrays to define the humoral immune response in leprosy patients and identification of disease-state-specific antigenic profiles. Infect. Immun. 74: 6458-6466. (Pubitemid 44657428)
32. Billeskov, R., C. Vingsbo-Lundberg, P. Andersen, and J. Dietrich. 2007. Induction of CD8 T cells against a novel epitope in TB10.4: correlation with mycobacterial virulence and the presence of a functional region of difference-1. J. Immunol. 179: 3973-3981.
33. Zhang, H., H. Hong, D. Li, S. Ma, Y. Di, A. Stoten, N. Haig, K. Di Gleria, Z. Yu, X. N. Xu, et al. 2009. Comparing pooled peptides with intact protein for accessing cross-presentation pathways for protective CD8+ and CD4+ T cells. J. Biol. Chem. 284: 9184-9191.
34. Bijker, M. S., S. J. van den Eeden, K. L. Franken, C. J. Melief, R. Offringa, and S. H. van der Burg. 2007. CD8+ CTL priming by exact peptide epitopes in incomplete Freund's adjuvant induces a vanishing CTL response, whereas long peptides induce sustained CTL reactivity. J. Immunol. 179: 5033-5040.
35. Pantaleo, G., and A. Harari. 2006. Functional signatures in antiviral T-cell immunity for monitoring virus-associated diseases. Nat. Rev. Immunol. 6: 417-423.
36. Harari, A., V. Rozot, F. B. Enders, M. Perreau, J. M. Stalder, L. P. Nicod, M. Cavassini, T. Calandra, C. L. Blanchet, K. Jaton, et al. 2011. Dominant TNF&lapha;+ Mycobacterium tuberculosis-specific CD4+ T cell responses discriminate between latent infection and active disease. Nat. Med. 17: 372-376.
37. Darrah, P. A., D. T. Patel, P. M. De Luca, R. W. Lindsay, D. F. Davey, B. J. Flynn, S. T. Hoff, P. Andersen, S. G. Reed, S. L. Morris, et al. 2007. Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major. Nat. Med. 13: 843-850. (Pubitemid 47038186)
38. Caccamo, N., G. Guggino, S. A. Joosten, G. Gelsomino, P. Di Carlo, L. Titone, D. Galati, M. Bocchino, A. Matarese, A. Salerno, et al. 2010. Multifunctional CD4(+) T cells correlate with active Mycobacterium tuberculosis infection. Eur. J. Immunol. 40: 2211-2220.
39. Kagina, B. M., B. Abel, T. J. Scriba, E. J. Hughes, A. Keyser, A. Soares, H. Gamieldien, M. Sidibana, M. Hatherill, S. Gelderbloem, et al; other members of the South African Tuberculosis Vaccine Initiative. 2010. Specific T cell frequency and cytokine expression profile do not correlate with protection against tuberculosis after bacillus Calmette-Guérin vaccination of newborns. Am. J. Respir. Crit. Care Med. 182: 1073-1079.
40. Chegou, N. N., G. F. Black, M. Kidd, P. D. van Helden, and G. Walzl. 2009. Host markers in QuantiFERON supernatants differentiate active TB from latent TB infection: preliminary report. BMC Pulm. Med. 9: 21.
41. Ruhwald, M., J. Petersen, K. Kofoed, H. Nakaoka, L. E. Cuevas, L. Lawson, S. B. Squire, J. Eugen-Olsen, and P. Ravn. 2008. Improving T-cell assays for the diagnosis of latent TB infection: potential of a diagnostic test based on IP-10. PLoS ONE 3: e2858.
42. Abramo, C., K. E. Meijgaarden, D. Garcia, K. L. Franken, M. R. Klein, A. J. Kolk, S. C. Oliveira, T. H. Ottenhoff, and H. C. Teixeira. 2006. Monokine induced by interferon gamma and IFN-gamma response to a fusion protein of Mycobacterium tuberculosis ESAT-6 and CFP-10 in Brazilian tuberculosis patients. Microbes Infect. 8: 45-51. (Pubitemid 43139291)
43. Maglione, P. J., and J. Chan. 2009. How B cells shape the immune response against Mycobacterium tuberculosis. Eur. J. Immunol. 39: 676-686.
44. Abebe, F., and G. Bjune. 2009. The protective role of antibody responses during Mycobacterium tuberculosis infection. Clin. Exp. Immunol. 157: 235-243.
45. Cronin, D. C., II, R. Stack, and F. W. Fitch. 1995. IL-4-producing CD8+ T cell clones can provide B cell help. J. Immunol. 154: 3118-3127.
46. Geluk, A., V. Taneja, K. E. van Meijgaarden, E. Zanelli, C. Abou-Zeid, J. E. Thole, R. R. de Vries, C. S. David, and T. H. Ottenhoff. 1998. Identification of HLA class II-restricted determinants of Mycobacterium tuberculosis-derived proteins by using HLA-transgenic, class II-deficient mice. Proc. Natl. Acad. Sci. USA 95: 10797-10802. (Pubitemid 28413148)